NEW YORK (dpa-AFX) – The US stock markets started the new stock market week without a clear direction. While the standard values on Wall Street were mostly in the red, the technology stocks on the Nasdaq continued their latest climb. Investors are focusing on the monetary policy comments and decisions of the US Federal Reserve announced for Wednesday. According to most analysts, the Fed will be extremely relaxed despite a recent sharp rise in inflation Monetary policy hold tight.
The Dow Jones Industrial (Dow Jones 30 Industrial) traded on Monday 0.76 percent lower at 34 218.16 points. The S&P 500, which represents the broad market, fell by 0.28 percent to 4235.75 meters. For the technology-heavy selection index NASDAQ 100, however, it rose 0.49 percent to 14 066.81 points. It is thus approaching the previous record high of 14 073 points at the end of April.
A corona vaccine once again hit the headlines on Monday, this time the one that has not yet been approved by Novavax. The BiotechCompany announced that its own active ingredient had shown itself to be highly effective in tests, including against mutations of the virus. According to the information, it should protect 90 percent from all symptoms, and 100 percent from severe courses. However, investors left it relatively cold: Novavax shares recently fell by 0.1 percent.
The share certificates of the popular corona vaccine manufacturers Biontech (BioNTech (ADRs)) and Moderna also had to give up. Biontech fell by more than 6 percent, Moderna papers lost 5.7 percent.
In the case of Oatly shares (Oatly AB), the first analyst assessments came into focus after the successful IPO. After a rally in the first few days from the $ 17 issue price to $ 28.73 on Friday, many experts are now approaching the oat drink manufacturer with a neutral vote, including renowned houses such as JPMorgan (JPMorgan ChaseCo) or Morgan Stanley. The papers slumped 8.0 percent due to profit-taking./edh/he
–
TRADE FOREIGN EXCHANGE WITH UP TO LEVER 30 NOW
Trade forex with high leverage and small spreads. With just € 100 you can benefit from the effect of € 3,000 in capital.
–
72% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you can afford the high risk of losing your money.
–
– .